Wang, J., Lai, X., Yao, H., Yang, H., Cao, X., Wang, X., . . . Ye, S. A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer. Springer.
Chicago Style (17th ed.) CitationWang, Jingshu, et al. A Multicenter, Randomized, Open Label, Two Formulation, Crossover Bioequivalence Trial of Doxorubicin Hydrochloride Liposomal Injection in Chinese Patients with Metastatic Breast Cancer. Springer.
MLA (9th ed.) CitationWang, Jingshu, et al. A Multicenter, Randomized, Open Label, Two Formulation, Crossover Bioequivalence Trial of Doxorubicin Hydrochloride Liposomal Injection in Chinese Patients with Metastatic Breast Cancer. Springer.
Warning: These citations may not always be 100% accurate.